MedPath

Comparison of the effect of duloxetine and imipramine on diarrhea treatment in patients with irritable bowel syndrome

Phase 2
Conditions
Irritable Bowel syndrom with diarrhea perdominnace.
K58
Irritable
Registration Number
IRCT20190703044084N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Patients with irritable bowel syndrome and diarrhea predominance between the ages of 18-40 years based on Rome III criteria

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diarrhea,abdominal pain,age,sex. Timepoint: Beginning of the study and 3 months later. Method of measurement: IBS severity score questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath